Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 6.870
Filter
1.
Rev. bras. med. esporte ; 29(spe1): e2022_0187, 2023. tab, graf
Article in English | LILACS | ID: biblio-1394856

ABSTRACT

ABSTRACT Introduction As college basketball continues to develop, more and more college students are joining the sport, and the resulting sports injuries have also gradually increased, affecting the quality of life and academic performance. Objective Analyze the most common sports injuries and offer solutions for the safe practice of college basketball. Methods This article studies, through interviews and literature review, the basketball injuries of college students, analyze the main causes of sports injuries, and presents corresponding countermeasures to promote the safe development of sports education in colleges. Results The main injuries were during training, excessive force, and inadequate preparation. Deficient muscle work is also associated with most of these injuries. Conclusion Basketball is highly competitive and popular on college campuses. It is a sport that can exercise and enrich the extracurricular life of college students, requiring from its practitioners greater attention in the pre-training warm-up phase and parallel muscle strengthening to reduce its major injuries in college students. Level of evidence II; Therapeutic studies - investigation of treatment outcomes


RESUMO Introdução Com o desenvolvimento contínuo do basquetebol universitário, cada vez mais estudantes universitários aderem ao esporte e as lesões esportivas resultantes também tem aumentado gradualmente, afetando a qualidade de vida e o desempenho nos estudos. Objetivo Analisar as lesões esportivas mais comuns e oferecer soluções visando a prática segura do basquetebol universitário. Métodos Este artigo estuda por meio de entrevistas e revisão literária as lesões no basquetebol dos estudantes universitários, analisa as principais causas das lesões no esporte e apresenta as contramedidas correspondentes para promover o desenvolvimento seguro do ensino esportivo em faculdades. Resultados As principais lesões encontradas foram durante o treino, excesso de força e preparo inadequado. O trabalho muscular deficitário também está associado a maior parte dessas lesões. Conclusão O basquetebol é um esporte altamente competitivo, muito popular nos campi universitários. É um esporte que pode exercitar e enriquecer a vida extracurricular dos estudantes universitários, requerendo de seus praticantes uma maior atenção na fase de aquecimento pré-treino e fortalecimento muscular paralelo para redução das suas principais lesões em universitários. Nível de evidência II; Estudos terapêuticos - investigação dos resultados do tratamento.


RESUMEN Introducción Con el continuo desarrollo del baloncesto universitario, cada vez más estudiantes universitarios se incorporan a este deporte y las lesiones deportivas resultantes también han aumentado gradualmente, afectando a la calidad de vida y al rendimiento en los estudios. Objetivo Analizar las lesiones deportivas más comunes y ofrecer soluciones orientadas a la práctica segura del baloncesto universitario. Métodos Este artículo estudia, mediante entrevistas y revisión de la literatura, las lesiones de baloncesto de los estudiantes universitarios, analiza las principales causas de las lesiones deportivas y presenta las correspondientes contramedidas para promover el desarrollo seguro de la enseñanza deportiva en los colegios. Resultados Las principales lesiones encontradas fueron durante el entrenamiento, la fuerza excesiva y la preparación inadecuada. El trabajo muscular deficiente también está asociado a la mayoría de estas lesiones. Conclusión El baloncesto es un deporte altamente competitivo, muy popular en los campus universitarios. Es un deporte que puede ejercitar y enriquecer la vida extraescolar de los universitarios, requiriendo de sus practicantes una mayor atención en la fase de calentamiento previo al entrenamiento y el fortalecimiento muscular paralelo para reducir sus principales lesiones en los universitarios. Nivel de evidencia II; Estudios terapéuticos - investigación de los resultados del tratamiento.


Subject(s)
Humans , Athletic Injuries/etiology , Basketball/injuries , Athletic Injuries/therapy , Severity of Illness Index , Interviews as Topic
2.
Arch. argent. pediatr ; 120(5): 332-335, oct. 2022. tab, ilus
Article in English, Spanish | LILACS, BINACIS | ID: biblio-1391165

ABSTRACT

Introducción. El objetivo del estudio fue analizar el índice de mortalidad pediátrica 3 (PIM 3) y la evaluación de falla orgánica secuencial pediátrica (pSOFA) para predicción de muerte. Métodos. Estudio observacional prospectivo; se incluyeron pacientes de 1 mes a 17,9 años. La precisión se evaluó con el área bajo la curva (AUC) y se estimó la tasa de mortalidad estandarizada. Resultados. Se estudiaron 244 ingresos; la mediana de edad fue 60 meses. Los diagnósticos principales fueron neoplasias sólidas o hematológicas (26,5 %). La mortalidad por ingresos fue del 18 % (44/244). Para PIM 3 el AUC fue de 0,77 y para pSOFA, de 0,81; ambas escalas mostraron adecuada calibración (p > 0,05). La tasa de mortalidad estandarizada fue de 1,91. Conclusiones. Identificamos que las escalas de evaluación de mortalidad PIM 3 y pSOFA muestran capacidad de discriminación aceptable. En pacientes con neoplasias sólidas o hematológicas, PIM 3 no mostró adecuada calibración.


Introduction. The study objective was to analyze the Pediatric Index of Mortality 3 (PIM 3) and the pediatric Sequential Organ Failure Assessment (pSOFA) for the prediction of mortality. Methods. Observational, prospective study; patients aged 1 month to 17.9 years were included. Assessment of area under the curve (AUC) accuracy and estimation of standardized mortality rate. Results. A total of 244 admissions were studied: median age was 60 months. The main diagnoses were solid or hematologic neoplasms (26.5%). The mortality by admission was 18% (44/244). The AUC was 0.77 for PIM 3 and 0.81 for pSOFA; both scales showed an adequate calibration (p > 0.05). The standardized mortality rate was 1.91. Conclusions. We identified that the PIM 3 and pSOFA have an acceptable discrimination power. The calibration of the PIM 3 was not adequate in patients with solid or hematologic neoplasms.


Subject(s)
Humans , Infant , Child, Preschool , Child , Adolescent , Intensive Care Units, Pediatric , Hematologic Neoplasms/diagnosis , Severity of Illness Index , Prospective Studies , Hospital Mortality , Organ Dysfunction Scores , Mexico
3.
Medwave ; 22(6): e002548, jul.-2022.
Article in English, Spanish | LILACS | ID: biblio-1381418

ABSTRACT

Introducción COVID- 19, es una enfermedad que ha cobrado la vida de muchas personas. Sin embargo, las alteraciones en los perfiles de labora-torio en la ciudad de Tacna, no han sido establecidas de manera precisa en asociacion a su gravedad para apoyo en el diagnostico y tratamiento. Objetivo Determinar los biomarcadores que esten relacionados al grado de severidad de los pacientes COVID- 19 atendidos en el hospital de la seguridad social, en Tacna durante 2020. Métodos Estudio observacional, transversal y analitico. Conformado por 308 pacientes con COVID- 19 del hospital de la seguridad social de la ciudad de Tacna, Peru, durante el golpe de la "primera ola" (de julio a agosto de 2020). Se recolectaron resultados de marcadores inmunologicos, hematologicos, gases arteriales, hemostasia y bioquimicos. Los pacientes se categorizaron en leves, moderados y severos, basandonos en el criterio medico ­ clinico de la historia clinica. Las correlaciones y fuerza de correlacion fueron realizadas segun coeficiente Rho de Spearman. El rendimiento de los biomarcadores asociado a la gravedad, se realizo con curva Receiver Operating Characteristic. Resultados En marcadores hematologicos existe correlacion positiva con recuento de monocitos (coeficiente de correlacion: 0,841; area bajo la curva 97,0%; p < 0,05) y correlacion negativa con recuento de linfocitos (coeficiente de correlacion: -0,622; area bajo la curva 8.27%; p < 0,05). En marcadores bioquimicos, gases arteriales y hemostasia, no se hallaron correlaciones significativas. En marcadores in-munologicos, encontramos correlacion positiva con ferritina (coeficiente de correlacion: 0,805; area bajo la curva 94,0%; p < 0,05), y proteina C reactiva (coeficiente de correlacion: 0,587; area bajo la curva 87,4%; p < 0,05). Conclusiones Los biomarcadores que pueden considerarse como parametros asociados a la gravedad de COVID- 19, son el recuento sanguineo absoluto de monocitos y la concentracion serica de ferritina.


Introduction COVID- 19 is a disease that has claimed the lives of many people. However, alterations in labo-ratory profiles in the city of Tacna have not been accurately established in association with its severity to support diagnosis and treatment. Objective To determine biomarkers related to the severity of COVID- 19 in patients treated at the social security hospital in Tacna during 2020. Methods We performed an observational, cross- sectional, and analytical study that included 308 patients with COVID- 19 from the social security hospital in Tacna, Peru, during the "first wave" of the pandemic (from July to August 2020). Immunological, hematological, arterial gas, hemostasis, and biochemical markers were collected. Patients were categorized into mild, moderate, and severe based on the clinical criteria found on clinical records. Correlation strength was per-formed according to Spearman's Rho coefficient. The performance of the biomarkers associat-ed with severity was analyzed with the Receiver Operating Characteristic curve. Results Regarding hematological markers there was a positive correlation with monocyte count (correla-tion coefficient: 0.841; area under the curve 97.0%; p < 0.05) and a negative correlation with lymphocyte count (correlation coefficient: -0.622; area under the curve 82.7%; p < 0.05). Regarding biochemical markers, arterial gases and hemostasis, no significant correlations were found. In immunological markers, we found positive correlation with ferritin (correlation coef-ficient: 0.805; area under the curve 94.0%; p < 0.05), and C- reactive protein (correlation coeffi-cient: 0.587; area under the curve 87.4%; p < 0.05). Conclusions The biomarkers that can be considered as parameters associated with the severity of COVID- 19 are the absolute blood count of monocytes and serum ferritin concentration.


Subject(s)
Humans , COVID-19/diagnosis , Severity of Illness Index , C-Reactive Protein/analysis , C-Reactive Protein/metabolism , Biomarkers , Retrospective Studies , Ferritins , Pandemics , SARS-CoV-2
4.
Bol. malariol. salud ambient ; 62(1): 32-38, jun, 2022. tab, ilus
Article in Spanish | LILACS, LIVECS | ID: biblio-1379293

ABSTRACT

Hay dos tipos principales de tejido adiposo; el subcutáneo, que es menos activo metabólicamente, y el tejido adiposo visceral, que secreta constantemente citocinas inflamatorias y está relacionado a enfermedades metabólicas y cardiovasculares. Nuestro objetivo fue identificar la asociación entre el exceso de grasa visceral y la severidad de enfermedad en pacientes con COVID-19. Se realizó un estudio observacional analítico que incluyó a pacientes con COVID-19 admitidos al Hospital Carrión de Huancayo, Perú. Se utilizó la balanza de bioimpedancia para cuantificar la composición corporal, la variable dependiente fue la severidad de enfermedad. Se utilizó el análisis de regresión logística para determinar la asociación de la grasa visceral y otros parámetros antropométricos con severidad de enfermedad. Se analizaron a 120 personas con COVID-19, la edad promedio fue 50 años, el sexo masculino fue 60%. De acuerdo a los valores de la composición corporal emitidos por el equipo de bioimpedancia: La grasa visceral > 15Kg (OR 7,31; p = 0,001); la grasa corporal total > 35% (OR 5,58; p = 0,009) y el exceso de peso > 20Kg (OR 6,96; p = 0,011) fueron los parámetros asociados a enfermedad severa por COVID-19. La relación positiva entre el perímetro abdominal y la cantidad de grasa visceral fue significativo (p = 0,01). En la composición corporal, el exceso de grasa visceral es el mayor parámetro asociado a enfermedad severa por COVID-19(AU)


There are two main types of adipose tissue; the subcutaneous, which is less metabolically active, and the visceral adipose tissue, which constantly secretes inflammatory cytokines and is related to metabolic and cardiovascular diseases. Our objetive was to identify the association between the excess of visceral fat and disease severity in COVID-19 patients. An analytical observational study was carried out which included patients with COVID-19 admitted to the Carrión Hospital in Huancayo, Peru. The bioimpedance balance was used to quantify the body composition; the dependent variable was the severity of the disease. A logistic regression analysis was used to determine the association of visceral fat and other anthropometric parameters with the severity of the disease. Out of 120 people with COVID-19 were analyzed, the average age was 50 years, the male sex was 60%. According to the body composition values issued by the bioimpedance team: Visceral fat> 15Kg (OR 7.31; p = 0.001); Total body fat> 35% (OR 5.58; p = 0.009) and excess weight> 20Kg (OR 6.96; p = 0.011) were the parameters associated with severe disease due to COVID-19. The positive relationship between abdominal circumference and the amount of visceral fat was significant (p = 0.01). In body composition, excess visceral fat is the main parameter associated with severe COVID-19 disease(AU)


Subject(s)
Humans , Male , Female , Adolescent , Adult , Aged , Aged, 80 and over , Respiratory Distress Syndrome, Newborn/epidemiology , Intra-Abdominal Fat/physiopathology , COVID-19/physiopathology , COVID-19/epidemiology , Obesity/physiopathology , Peru/epidemiology , Severity of Illness Index , Body Mass Index , Logistic Models , Regression Analysis , Hospitals
5.
Arch. argent. pediatr ; 120(3): 180-186, junio 2022.
Article in English, Spanish | LILACS, BINACIS | ID: biblio-1368150

ABSTRACT

Introducción. La exostosis múltiple hereditaria es una enfermedad poco frecuente autosómica dominante caracterizada por presencia de múltiples proyecciones óseas. Objetivo. Analizar factores asociados a la calidad de vida relacionada con la salud (CVRS) en niños >2 años y en adultos en seguimiento en un hospital de pediatría de alta complejidad de Argentina. Población y métodos. Estudio transversal de una cohorte en seguimiento. La CVRS se midió con Pediatric Quality of Life Inventory (PedsQL) y Short Form Health Survey (SF-36). Se registró sexo, edad, características sociodemográficas, estatura, radiología, alteración de eje y función de miembros, presencia de dolor y malignización. Se clasificó la gravedad según Pedrini y col. Se realizaron pruebas paramétricas, no paramétricas y análisis de regresión. Resultados. Se incluyeron 66 casos (47 niños y 19 adultos). Relación sexo masculino/femenino: 1,7/1. Mediana de edad: 13,4 años (r: 2,2155,3). Presentaron dolor 30 de 47 niños y 17 de 19 adultos. Si se considera la edad ósea adulta (o cierre epifisario) como punto de corte para definir el estado de adulto, 11 de 37 niños y 18 de 27 adultos presentaron forma grave de enfermedad, y se observó baja estatura en 2 de 38 niños y en 9 de 27 adultos. El valor promedio del componente físico de CVRS en niños fue 65,9 (DE: 22,5) y, en adultos, 27,2 (RIC: 18,5-34,7). La presencia de dolor y la gravedad clínica se asoció significativamente a menor CVRS tanto en niños como en adultos. Conclusiones. En este estudio se observó que el dolor y la gravedad de la enfermedad tuvieron un efecto negativo en la CVRS.


Introduction. Hereditary osteochondromatosis is an uncommon, autosomal, dominant condition characterized by the presence of multiple bone growths. Objective. To analyze factors associated with health-related quality of life (HRQoL) among children > 2 years and adults receiving follow-up at a tertiary care children's hospital in Argentina. Population and methods. Cross-sectional study of a follow-up cohort. HRQoL was measured using the Pediatric Quality of Life Inventory (PedsQL) and the Short Form Health Survey (SF36). Sex, age, sociodemographic characteristics, height, radiology, axis alteration and limb function, presence of pain, and malignant change were recorded. Severity was classified as per Pedrini et al. Parametric and non-parametric tests and regression analysis were done. Results. A total of 66 cases (47 children and 19 adults) were included. Male/female ratio: 1.7/1. Median age: 13.4 years (r: 2.21-55.3). Pain was observed in 30/47 children and in 17/19 adults. Considering the adult bone age (or epiphyseal closure) as the cutoff point to define adult status, 11/37 children and 18/27 adults had a severe disease and 2/38 children and 9/27 adults had short stature. The average value of the physical component of HRQoL in children was 65.9 (SD: 22.5) and, in adults, 27.2 (IQR: 18.534.7). The presence of pain and clinical severity were significantly associated with a lower HRQoL, both in children and adults. Conclusions. This study found that pain and disease severity had a negative effect on HRQoL.


Subject(s)
Humans , Child, Preschool , Child , Adolescent , Quality of Life , Osteochondromatosis , Pain , Severity of Illness Index , Cross-Sectional Studies , Surveys and Questionnaires
6.
Brasília; CONITEC; maio 2022.
Non-conventional in Portuguese | LILACS, BRISA | ID: biblio-1368825

ABSTRACT

INTRODUÇÃO: Pacientes com fatores de risco como idade avançada, imunodepressão, obesidade e doenças cardiovasculares têm risco aumentado de internação, intubação e morte. De acordo com dados brasileiros, o risco de morte por Covid-19 aumenta com o número de fatores de risco que o paciente apresenta, sendo igual a 17% em pacientes com 2 fatores de risco e 76% na presença de 8 fatores de risco. Além disso, mesmo aqueles pacientes que sobrevivem a uma internação em terapia intensiva frequentemente enfrentam sequelas e representam alto custo para o sistema público. O medicamento nirmatrelvir associado ao ritonavir têm o objetivo de prevenir internações, complicações e morte. Ele é indicado para pacientes com Covid-19 leve a moderada, não hospitalizados, até 5 dias do início dos sintomas. Apesar dos avanços da vacinação no Brasil, evidências sobre a falha vacinal em idosos e imunodeprimidos destacam a importância da disponibilidade de alternativas terapêuticas para


Subject(s)
Humans , Severity of Illness Index , Ritonavir/therapeutic use , Chymases/antagonists & inhibitors , SARS-CoV-2/drug effects , COVID-19/drug therapy , Unified Health System , Brazil , Cost-Benefit Analysis/economics
7.
Lima; Instituto Nacional de Salud; abr. 2022.
Non-conventional in Spanish | LILACS, BRISA | ID: biblio-1369443

ABSTRACT

INTRODUCCIÓN: Según la OMS, la pandemia por COVID-19 ha causado más de 494 587 638 casos confirmados de COVID-19, más de 6 170 283 de defunciones a nivel global y 151 489 694 de casos confirmados en la región de las Américas hasta el día 11 de abril de 2022 (1). Después de sufrir la infección aguda por el SARS-CoV-2, la mayoría de los pacientes de COVID-19 regresan a su estado de salud inicial, pero una proporción de ellos subsisten los problemas de salud. En septiembre de 2020, la unidad de Clasificación y Terminología de la OMS creó los códigos CEI-10 y CEI-11 para las "afecciones post-COVID-19", con la necesidad de eliminar la ambigüedad entre enfermedad aguda, efectos tardíos o curso prolongado llevó a la ormulación neutral "post-covid". La enfermedad del COVID-19 causa distintas manifestaciones clínicas; sin embargo, no todos los pacientes se recuperan tras una fase aguda y se recuperan por completo, algunos siguen manifestando efectos a largo plazo en diversos sistemas orgánicos, incluidos los sistemas pulmonar, cardiovascular y nervioso, así como efectos psicológicos. Aún no se sabe cuántas personas están afectadas por secuelas a largo plazo después de sufrir la infección aguda por el SARS-CoV-2, pero los informes publicados indican que aproximadamente entre el 10% y el 20% de los pacientes de COVID-19 experimentan síntomas persistentes durante semanas o meses posteriores a padecer la enfermedad. El 6 de octubre de 2021, el grupo de trabajo de la OMS a través de la metodología Delphi se realizó una definición de caso clínico de afección pos-COVID-19, estás definiciones varían y se han propuesto distintas terminologías incluidas como COVID prolongada, COVID de larga duración o afección pos-COVID-19 está ultima recomendada por la OMS. La afección pos-COVID-19 afecta a personas con un historial de infección presunta o confirmada por el SARS-CoV-2, generalmente tres meses después de contraer la COVID-19, con síntomas que duran al menos dos meses y que no pueden explicarse por un diagnóstico alternativo. Los síntomas más comunes incluyen fatiga, dificultad respiratoria y disfunción cognitiva, pero también otros que generalmente afectan el funcionamiento en la vida cotidiana. OBJETIVO: Sintetizar la evidencia científica publicada respecto a la prevalencia, manifestaciones clínicas y factores asociados al desarrollo de COVID-19 de larga duración. MÉTODOS: Formulación de las preguntas PICO: En pacientes adultos con antecedente de infección por SARS-CoV-2, ¿cuál es la prevalencia de COVID-19 de larga duración, y cuáles son sus síntomas? En pacientes adultos con antecedente de infección por SARS-CoV-2, cuáles son los factores asociados al desarrollo de COVID-19 de larga duración? Criterios de elegibilidad: Los criterios de inclusión fueron los siguientes: Revisiones sistemáticas (RS) o revisiones rápidas (RR) de estudios de cohorte o estudios transversales, que reporten resultados para los desenlaces previstos. Estudios publicados en idioma inglés y español. Criterios de exclusión: Revisiones sistemáticas que no hayan efectuado una evaluación del riesgo de sesgo o calidad metodológica de los estudios incluidos. Revisiones sistemáticas focalizadas en sólo un grupo de síntomas. Se excluyeron cartas al editor, revisiones narrativas, estudios preclínicos (estudios in vitro o en modelos animales) y artículos de opinión. Métodos para la búsqueda e identificación de la evidencia: Para la identificación de las revisiones sistemáticas (RS) se efectuó una búsqueda en MEDLINE a través de Pubmed el 7 de abril de 2022, empleando términos MESH y términos libres para "COVID-19 de larga duración". Este informe constituye un reporte breve, la selección y extracción de los datos fue realizada de forma individual por todos los autores. Se efectuó una evaluación pareada e independiente de la calidad metodológica de las revisiones identificadas, mediante la herramienta AMSTAR 2 (4). Aquellas RS con mejor puntaje fueron incluidas. Para la síntesis de los datos, evaluación de riesgo de sesgo, se consideró la información proporcionada por la RS con mejor puntaje de AMSTAR 2. RESULTADOS: Se identificaron 37 citaciones a través de la búsqueda sistemática. El tamizaje por título y resumen seleccionó a 22 artículos y, de éstos, 8 fueron identificados mediante la lectura de texto completo. Luego de verificar los criterios de elegibilidad y aplicar la herramienta AMSTAR 2, se seleccionaron 3 revisiones sistemáticas que son la fuente para este informe(5­7). En el Anexo 2 se reporta el resultado de la evaluación según AMSTAR 2. CONCLUSIONES: El objetivo de este informe es sintetizar la evidencia científica publicada respecto a la prevalencia, manifestaciones clínicas y factores asociados al desarrollo de COVID-19 de larga duración. La afección post COVID-19 o COVID-19 de larga duración o Long COVID-19, se define como la enfermedad que contraen personas con antecedentes de infección probable o confirmada por el SARS-CoV-2; normalmente en los tres meses siguientes al inicio de la COVID-19, con síntomas y efectos que duran al menos dos meses. La prevalencia reportada de COVID-19 de larga duración es del 43% (IC95%: 35% ­ 51%). Las manifestaciones clínicas más comunes incluyen debilidad (41% [IC95%: 25 ­ 59]), malestar general (33% [IC95%: 15 ­ 57]), fatiga (31% [IC95%: 24­ 39]), alteración en la concentración (26% [IC95%: 21 ­ 32]) y sensación de falta de aire (25% [IC95%: 18 ­ 34]). Los síntomas más comunes pueden ser de nueva aparición, tras un periodo de recuperación inicial de un episodio agudo de COVID-19, o persistir desde la enfermedad inicial. Los síntomas como fatiga, sensación de falta de aire, pérdida de peso y alteración en la olfacción son más frecuentes en pacientes hospitalizados que en no hospitalizados. Las pruebas de diagnóstico por imágenes y las pruebas funcionales muestran que hay alteraciones como consolidación pulmonar, patrón reticulado, imágenes residuales en vidrio esmerilado. Estas alteraciones fueron mejorando en los seguimientos a los pacientes. La existencia de factores asociados a la persistencia de síntomas de COVID-19 de larga duración fueron evaluados en personas con antecedente de hospitalización durante el cuadro agudo, con un seguimiento de al menos 12 semanas. Los estudios fueron muy heterogéneos respecto a definiciones de los factores y los desenlaces, duración y método para el seguimiento y limitaciones metodológicas. En conjunto, se reportó asociación entre: Sexo femenino y cualquier síntoma de COVID-19 de larga duración, síntomas de salud mental y fatiga. La severidad del cuadro inicial estuvo asociada con un mayor riesgo de síntomas respiratorios. A mayor edad se observó un aumento en el deterioro del estado funcional medido con una escala de estado funcional post-COVID-19. Mientras que la edad mayor de 56 o 60 años, se asoció a puntajes bajos de calidad de vida y persistencia de síntomas a los 3 meses de seguimiento. Tener 2 o más comorbilidades fueron factores de riesgo para la persistencia de síntomas y la presencia de anormalidades espirométricas a los 3 meses del alta hospitalaria fue más frecuente con antecedentes de enfermedad cardiovascular y diabetes.


Subject(s)
Humans , Severity of Illness Index , SARS-CoV-2 , COVID-19/epidemiology , Prevalence , Cost-Benefit Analysis
8.
Actual. SIDA. infectol ; 30(108): 58-67, 20220000. graf, tab
Article in Spanish | LILACS, BINACIS | ID: biblio-1363381

ABSTRACT

ntroducción: La información sobre la evolución de la infección por COVID-19 en personas gestantes (PG) continúa en desarrollo.Objetivos: Describir la presentación de la infección por Sars-CoV-2 en PG y determinar variables asociadas a mayor gravedad.Materiales y métodos: Estudio observacional retrospectivo. Periodo: 01/03/2020-31/07/2021. Se incluyeron PG con diagnóstico de COVID-19 asistidas en una maternidad de gestión pública: se clasificaron según gravedad y se dividieron en dos grupos: Grup o1 leve y de manejo ambulatorio; Grupo 2 moderado, severo y crítico, con internación. Se analizó la relación entre gravedad y obesidad, DBT, hipertensión inducida por el embarazo (HIE), edad gestacional, edad materna, vacunación antigripal. Recién nacidos (RN) de madres infectadas se estudiaron con PCR para Sars-CoV-2 24-48 hs postnacimiento. Análisis estadístico: Chi-cuadrado o test exacto de Fisher. Significancia= p<0,05. Aprobado porComité Ética Institucional.Resultados: 52 PG con diagnóstico de COVID-19. Edadmediana 29,6 años. Grupo 1: 29 PG (55,5%). Grupo 2: 23 PG(44%), 19 (36,5%) moderados, 2 (4%) severos y 2 (4%) críticos. No hubo fallecimientos maternos ni fetales. Edad gestacional ≥ 28 semanas fue la única variable asociada a mayor gravedad,p=0,00004. 48% de los embarazos finalizaron por cesárea.48/52 RN fueron estudiados con PCR para Sars-CoV-2, siendo 1 (2%) positivo (fue el único RN sintomático).Conclusiones: La infección por COVID-19 en PG se asoció a presentaciones clínicas más graves cuando la infecciónse cursó en el tercer trimestre de gestación y se asociócon mayor incidencia de cesáreas


ntroduction: The information concerning the impact of COVID-19 infection in pregnant people (PP) continues to be established.Aim: to describe the evolution of the Sars-CoV-2 infection in pregnant people and to determine variables associated with clinical severity.Materials and Methods: Retrospective observational study. Period: 01-03-2020 to 31-07-2021. We included PP with diagnosis of COVID-19, assisted in a public maternity hospital. The cases were classified according to clinical severity based on the NIH guidelines. The patients were divided into 2 groups: Group 1: mild (ambulatory manage-ment). Group 2: moderate, severe and critical (requiring hospitalization). The relationship between variables and clinical severity was analyzed. Variables studied: obesity, DBT, gestational hypertension, gestational age, maternal age, influenza vaccination. Newborns of infected mothers were studied with PCR for Sars-CoV-2 24 to 48 hours af-ter birth. Statistical analysis: Chi-square or Fisher's exact test, significance = p <0.05. Study approved by the Institu-tional Ethics Committee.Results: 52 PP with diagnosis of COVID-19 were includ-ed. Median age 29.6 years. 23 patients (44%) required hospitalization and 2 (4%) MRA (mechanical respiratory assistance). 29 (55.5%) were mild, 19 (36.5%) moderate, 2 (4%) severe, and 2 (4%) critical. There were no mater-nal or fetal deaths. Gestational age ≥ 28 weeks was the only variable associated with more severe clinical forms, p = 0.0001. 48% of the pregnancies ended by cesarean section. 48/52 newborns were studied with PCR for Sars-CoV-2, with only 1 (2%) being positive. This was the only symptomatic newborn.Conclusions: In our study, Sars-CoV-2 infection during pregnancy was associated with more severe clinical pre-sentations when the infection occurred in the 3rd trimes-ter of pregnancy. COVID-19 was also associated with a higher incidence of ter


Subject(s)
Humans , Female , Pregnancy , Infant, Newborn , Adult , Young Adult , Severity of Illness Index , Gestational Age , COVID-19/complications , Pregnancy Complications/prevention & control , Pregnancy Trimester, Third , Cesarean Section , Retrospective Studies , Postpartum Period , COVID-19/diagnosis
9.
Arq. neuropsiquiatr ; 80(2): 137-144, Feb. 2022. tab, graf
Article in English | LILACS | ID: biblio-1364372

ABSTRACT

ABSTRACT Background: Spinocerebellar ataxias (SCAs) are a group of neurodegenerative diseases characterized by deterioration of balance and functionality that tends to follow disease progression. There is no established link between formal clinical markers for severity and functional/balance scores that could guide rehabilitation teams. Objective: To evaluate the relationship between functional scales and ataxia severity in order to identify cutoff landmarks for functional loss and estimate the mean SARA (Scale for Assessment and Rating of Ataxia) score for the risk ratings for falls on the BBS (Berg Balance Scale). Methods: Consecutive patients with a molecular diagnosis of SCA (total 89: 31 with SCA2 and 58 with SCA3) were assessed for functionality FIM-ADL (Functional Independence Measure-activities of daily living and Lawton-IADL (instrumental activities of daily living), balance (BBS) and disease severity (SARA). Results: The main disability cutoff landmarks were that the need for supervision for FIM-ADL starts with 12 points on SARA and the need for supervision for Lawton-IADL starts with 14 points on SARA. The first items to require assistance were "expression" and "shopping", respectively. At 20 points on SARA, patients were dependent on all FIM and Lawton items. The item with the greatest impact on distinguishing dependents from independents was "means of transport" in Lawton-IADL and the domain "locomotion" in FIM-ADL. The mean SARA score for patients classified as low risk in the BBS was 9.9 points, and it was 17.4 for medium risk and 25.2 for high risk. Conclusions: Analysis on the correlation between the severity of ataxia and functional scales can form an important guide for understanding the progression of functional dependence among individuals with SCAs.


RESUMO Antecedentes: As ataxias espinocerebelares (SCA) são um grupo de doenças neurodegenerativas caracterizadas pela deterioração do equilíbrio e da funcionalidade, que tende a acompanhar a progressão da doença. Não existe uma ligação estabelecida entre os marcadores clínicos formais de gravidade e escores funcionais e de equilíbrio que possam orientar as equipes de reabilitação. Objetivo: Avaliar a relação entre escalas funcionais e de gravidade da ataxia, buscando identificar pontos de corte para a perda funcional relacionados aos escores de gravidade e aos patamares de Risco de Quedas. Métodos: Uma amostra consecutiva de 89 pacientes com diagnóstico molecular de SCA (31-SCA2 e 58-SCA3) foram avaliados para funcionalidade MIF-AVDs (Medida de independência funcional-Atividades da vida diária) e Lawton-AIVDs (Atividades instrumentais da vida diária), equilíbrio (EEB-escala de Equilíbrio de Berg), e gravidade da ataxia (SARA-escala para avaliação e graduação de ataxia). Resultados: Os principais pontos de corte de deficiência foram: com 12 pontos no SARA começa a necessidade de supervisão para MIF-AVDs e com 14 pontos no SARA começa a necessidade de supervisão para Lawton-AIVDs. Os primeiros itens a necessitar de assistência foram "expressão" e "compras", respectivamente. Com 20 pontos no SARA os pacientes eram dependentes em todos os itens MIF/LAWTON. O item com maior impacto na discriminação entre dependentes e independentes foi "meio de transporte" na Lawton e o domínio "locomoção" na MIF. O escore médio no SARA foi de 9,9 pontos para pacientes classificados com baixo risco na EEB, 17,4 para médio risco e 25,2 para alto risco. Conclusões: A análise da correlação entre a gravidade da ataxia e as escalas funcionais pode ser um importante guia no entendimento da progressão da dependência funcional em indivíduos com SCA.


Subject(s)
Humans , Activities of Daily Living , Spinocerebellar Ataxias , Severity of Illness Index
11.
Mediterr J Pharm Pharm Sci ; 2(1): 65-72, 2022. figures, tables
Article in English | AIM | ID: biblio-1363903

ABSTRACT

Abstract: Vitamin D is a hormone which plays a vital role in immune response regulation, including the prevention of inflammation and autoimmunity. Insufficient vitamin D may increase the risk of infection. Vitamin D deficiency is not the only factor linked to an elevated risk of COVID-19 infection. Recent studies have discovered a link between SARS-COV-2 infection risk and blood type. This study was aimed to examine the association of vitamin D and blood groups with the severity of COVID-19. A retrospective study was conducted on 224 confirmed COVID-19 patients, aged between 18 and 89 years old. Patients were divided into three groups (asymptomatic, moderate, and severe cases), and serum 25(OH)D concentration and blood group were analyzed for all the patients. Data of the severe cases were obtained from Souq Althalath Isolation Center, Tripoli, Libya, while moderate and asymptomatic cases were obtained from Abushusha Polyclinic and Aldahmani COVID Filtration Center, during 22nd February 2021 and 28th April 2021 and serum 25(OH)D concentration and blood group were statistically analyzed for all the patients. The percentages of males andfemales were found to be 47.3% and 52.7%, respectively. Disease severity was distributed as follows: 12.5% asymptomatic, 44.6 % moderate and 42.9% severe. Most of the severe cases had vitamin D deficiency (88.5%). Among the severely ill patients, 39.6% had blood group A and 09.4% had group O, while 22.9%, and 28.1% had blood group B and AB, respectively. In contrast, among the asymptomatic patients, only 7.1% had group A and 85.7% had group O. Overall, the difference in the distribution pattern of blood group in the three severity categories was highly significant (p < 0.001). The prevalence of Rh positivity among asymptomatic, moderate and severe cases was 78.6%, 76.0%, and 60.4%, respectively. This study concludes that insufficient vitamin D levels might influence the severity of COVID-19. COVID-19 patients with blood group A and those who are Rh-positive could be more vulnerable to developing COVID-19 severity


Subject(s)
Humans , Male , Female , Blood Group Antigens , SARS-CoV-2 , COVID-19 , Severity of Illness Index
12.
Niger. Postgrad. Med. J. ; 29(3): 198-205, 2022. figures, tables
Article in English | AIM | ID: biblio-1380942

ABSTRACT

Introduction: Severe malaria is a leading cause of mortality due to late presentation to health facilities. Hence, there is a need to identify and mitigate factors promoting delayed presentation with severe malaria. Objective: This study aimed to evaluate determinants of delayed presentation of children with severe malaria in a tertiary referral hospital. Methods: This study adopted a descriptive, cross-sectional design. The participants were children with a diagnosis of severe malaria, based on WHO diagnostic criteria. Delayed presentation was defined as presentation at the referral centre at >3 days of illness. Inferential analyses were done to identify factors associated with delayed presentation. P < 0.05 was considered statistically significant. Results: A total of 126 children with severe malaria participated in the study; their mean (standard deviation) age was 4.2 (5.3) years. The prevalence of delayed presentation in this study is 37.3%. Socio-economic class (P = 0.003); marital status (P = 0.015) and the number of health facilities visited before admission in the referral centre (P = 0.008) were significantly associated with delayed presentation. Children from upper socio-economic class were thrice more likely to present late, compared to those from lower social class (odds ratio [OR] = 3.728, 95% confidence interval [CI]: 1.694­8.208; P = 0.001). Likewise, the Yorubas were more delayed than the Binis (OR = 0.408, 95% CI: 0.180­0.928; P = 0.033). There was a negative correlation between caregivers' perception of treatment (r = −0.113, P = 0.21) of convulsion in severe malaria and timing of presentation. Conclusions: Delayed presentation is common with multifactorial determinants in the setting. Health education of caregivers on the consequences of delayed presentation in severe malaria is desirable.


Subject(s)
Humans , Male , Female , Referral and Consultation , Severity of Illness Index , Malaria, Falciparum , Caregivers , Health Facilities , Perception
13.
Annals of African Medical Research ; 5(1): 1-6, 2022. tables, figures
Article in English | AIM | ID: biblio-1380764

ABSTRACT

The aim of this study is to compare the prevalence, severity, and symptoms of Distal Symmetrical Polyneuropathy (DSP) among adult patients with diabetes and those without diabetes in a primary care clinic. It was a cross-sectional comparative study involving 72 adults of between 40-60 years of age living with diabetes and 72 age-matched adults without diabetes. DSP was assessed with a biothesiometer device, and data analysis was performed using the SPSS Version 21 statistical software. The overall prevalence of neuropathy among the participants was 68.1% for those living with diabetes and 38.9% for the other group. Furthermore, 22.3% of the diabetes group had severe neuropathy compared with 8.3% of the other group. These differences were found to be statistically significant with p=0.001 (df = 2, X2 = 14.07). We reported higher prevalence and severity of DSP in those living with diabetes. We also found significant association between high VPT (≥25V) and presence of neuropathic symptoms thereby enhancing the use of the biothesiometer device in the diagnosis of adults with DSP in the primary care setting.


Subject(s)
Humans , Adult , Paresthesia , Severity of Illness Index , Polyneuropathies , Prevalence , Adult , Diabetes Mellitus, Type 2
14.
Rev. Méd. Inst. Mex. Seguro Soc ; 60(1): 67-74, 2022. tab, graf
Article in Spanish | LILACS | ID: biblio-1361391

ABSTRACT

Se presenta un modelo departamental para la atención integral de pacientes con hipertensión pulmonar. Se resume el conocimiento actual de la hipertensión pulmonar, su mortalidad, pronóstico y la estratificación de su severidad que justifican la propuesta de la estructura y la función departamental.


A departmental model for the comprehensive care of patients with pulmonary hypertension is presented. The current knowledge of pulmonary hypertension, its mortality, prognosis and the stratification of its severity that justify the proposal of the departmental structure and function are summarized.


Subject(s)
Humans , Comprehensive Health Care/organization & administration , Hospital Departments/organization & administration , Hypertension, Pulmonary/diagnosis , Hypertension, Pulmonary/therapy , Prognosis , Severity of Illness Index , Risk Assessment , Pulmonary Arterial Hypertension/diagnosis , Pulmonary Arterial Hypertension/mortality , Pulmonary Arterial Hypertension/therapy , Hypertension, Pulmonary/epidemiology
15.
Bol. malariol. salud ambient ; 62(3): 376-382, 2022.
Article in Spanish | LILACS, LIVECS | ID: biblio-1395364

ABSTRACT

En la actualidad se han encontrado múltiples variables clínicas y paraclínicas predictores de pronóstico en pacientes con COVID-19. La identificación de los factores pronósticos, permitirá graduar el riesgo de los pacientes y controlar activamente la gravedad de la enfermedad. El objetivo de este artículo era identificar, a través de una revisión bibliográfica, las variables que puede estar asociado a desenlace fatal a causa de la infección por SARS-CoV-2, un panorama que anticipe a la severidad en pacientes con COVID-19. Por tanto, se confirma que la edad avanzadas conjuntamente con comorbilidades preexistente como: diabetes, hipertensión y otras enfermedades cardiovasculares, insuficiencia renal aguda, enfermedad hepática crónica, además de factores genéticos y demencia neurodegenerativa, son factores de mal pronóstico, en los pacientes con COVID-19(AU)


Currently, multiple clinical and paraclinical variables have been found to predict prognosis in patients with COVID-19. The identification of prognostic factors will allow patients' risk to be graded and actively control the severity of the desease. The goal of this article was to identify, through a bibliographic review, the variables that may be associated with a fatal outcome due to SARS-CoV-2 infection, a scenario that anticipates severity in patients with COVID-19. Therefore, it is confirmed that advanced age together with pre-existing comorbidities such as: diabetes, hypertension and other cardiovascular diseases, acute renal failure, chronic liver disease, in addition to genetic factors and neurodegenerative dementia, are poor prognostic factors in patients with COVID-19(AU)


Subject(s)
Prognosis , Severity of Illness Index , Comorbidity , COVID-19/complications , Signs and Symptoms , Cardiovascular Diseases
16.
Article in Chinese | WPRIM | ID: wpr-941033

ABSTRACT

OBJECTIVE@#To explore the correlation of coagulation function with the severity and prognosis of acute pancreatitis (AP) and identify the laboratory markers for early prediction and dynamic monitoring of the prognosis of AP.@*METHODS@#We retrospectively analyzed the clinical data of patients with AP admitted less than 72 h after onset to our hospital from December 1, 2017 to November 30, 2018. The correlation of coagulation function-related markers at admission and their changes during hospitalization with the prognosis of the patients was analyzed.@*RESULTS@#We screened the data of a total of 1260 patients with AP against the inclusion and exclusion criteria, and eventually 175 patients were enrolled in this analysis, among whom 52 patients had severe AP (SAP) and 12 patients died. Logistic regression analysis identified vWF: Ag, PT, PC, AT Ⅲ and D-dimer markers at admission as independent risk factors for predicting SAP and death. Dynamic monitoring of the changes in coagulation function-related markers in the disease course had greater predictive value of the patients' prognosis, and the indicators including vWF: Agmax, PTmax, APTTmax, TTmax, FIBmin, D-dimermax, PLTmin, PCmin, PLGmin, AT Ⅲmin, and their variations were all independent risk factors for predicting SAP and death. ROC analysis suggested that dynamic monitoring of the changes in the indicators, especially those of △vWF: Ag, △PT, △APTT, △FIB, △TT, △D-dimer, △PLT, △PC, △AT Ⅲ, △PLG, could effectively predict SAP and death in these patients (with AUC range of 0.63-0.84).@*CONCLUSION@#Patients with AP have vascular endothelial injuries and coagulation disorders. The markers including vWF: Ag, PT, PC, AT Ⅲ and D-dimer at admission are independent risk factors for predicting SAP and death, and dynamic monitoring of the changes in vWF: Ag、PT、APTT、TT、FIB、D-dimer、PLT、PC、AT Ⅲ and PLG can further increase the predictive value.


Subject(s)
Acute Disease , Biomarkers , Humans , Pancreatitis/diagnosis , Prognosis , ROC Curve , Retrospective Studies , Severity of Illness Index , von Willebrand Factor
17.
Article in Chinese | WPRIM | ID: wpr-941032

ABSTRACT

OBJECTIVE@#To assess the value of Improved Mayo Endoscopic Score (IMES) for evaluation of the clinical severity of ulcerative colitis (UC).@*METHODS@#We retrospectively analyzed the clinical and endoscopic data of 167 patients diagnosed with UC in Beijing Tsinghua Changgung Hospital from January, 2015 to November, 2021. The severity of endoscopic lesions was determined by Mayo Endoscopic Score (MES, 0-3 points) and the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) score (0-8 points), and the scope of endoscopic lesions was evaluated based on the Montreal classification system. The IMES was established by combining the MES with the Montreal classification.@*RESULTS@#The IMSE showed stronger correlations with modified Truelove and Witts Disease Severity, Mayo score and partial Mayo score (r=0.712, 0.784, and 0.703, respectively) than MES (r=0.642, 0.754, and 0.604, respectively), Montreal classification (r=0.598, 0.628, and 0.603, respectively) and UCEIS (r= 0.670, 0.767, and 0.677, respectively). ROC curve analysis showed that IMES was superior to MES, Montreal and UCEIS in diagnosis of severe and moderate- to-severe UC. IMES also showed stronger correlations with the laboratory indicators including CRP (r=0.583), WBC (r=0.235), HB (r=-0.280), PLT (r=0.352), ALB (r=-0.396) and ESR (r=0.471) than MES and Montreal classification. An IMES score of 5 was of greater value than a MES score of 3, E3, and UCEIS≥6 for predicting the administration of systemic hormones, immunosuppressants, or surgery in the near future.@*CONCLUSION@#IMES can better reflect the clinical severity of UC and has good correlations with the laboratory indicators of the patients.


Subject(s)
Colitis, Ulcerative/diagnosis , Colonoscopy , Humans , ROC Curve , Retrospective Studies , Severity of Illness Index
18.
Chinese Journal of Hepatology ; (12): 279-284, 2022.
Article in Chinese | WPRIM | ID: wpr-935938

ABSTRACT

Objective: Autologous peripheral blood stem cells (PBSC) derived from bone marrow can promote liver regeneration and improve the liver function of patients, but there are few studies on its effect on the long-term outcomes in patients with decompensated cirrhosis. Based on previous work, this study observed the clinical outcomes of PBSC treatment in patients with decompensated cirrhosis for 10 years, in order to provide more data support for the safety and efficacy of stem cells in clinical applications. Methods: Data of patients with decompensated liver cirrhosis who completed PBSC treatment in the Department of Gastroenterology of the First Affiliated Hospital of Air Force Military Medical University from August 2005 to February 2012 were included. The follow-up endpoint was death or liver transplantation, and patients who did not reach the follow-up endpoint were followed-up for at least 10 years. The patients with decompensated liver cirrhosis who met the conditions for PBSC treatment but did not receive PBSC treatment in our hospital during the same period were used as controls. Results: A total of 287 cases with decompensated liver cirrhosis had completed PBSC treatment, and 90 cases were lost to follow-up within 10 years after surgery. A total of 151 cases with complete survival follow-up data were included in the control group. There were no statistically significant differences in baseline information such as gender, age, etiological composition and liver function score between the two groups. The 10-year survival rate was higher in PBSC than control group (37.56% vs. 26.49%, P<0.05). Cholinesterase, albumin, international normalized ratio, Child-Turcotte-Pugh score, model for end-stage liver disease score, and other indicators were gradually recovered within 3 months to 1 year after PBSC treatment, and stabilized at a more desirable level in the long-term after follow-up for up to 10 years. There was no statistically significant difference in the incidence of liver cancer between the two groups (25.22% vs.31.85%, P=0.267). The age of onset of hepatocellular carcinoma was later in PBSC than control group [(56.66±7.21) years vs. (52.69±8.42) years, P<0.05]. Conclusions: This long-term observational follow-up study of more than ten years confirms that PBSC treatment can bring long-term benefits to patients with decompensated cirrhosis, with good long-term safety, thus providing more data support on the safety and efficacy of stem cells for clinical applications.


Subject(s)
End Stage Liver Disease , Follow-Up Studies , Humans , Liver Cirrhosis/drug therapy , Middle Aged , Peripheral Blood Stem Cells , Severity of Illness Index , Treatment Outcome
19.
Chinese Journal of Hepatology ; (12): 69-73, 2022.
Article in Chinese | WPRIM | ID: wpr-935910

ABSTRACT

Objective: To analyze the clinical features and prognosis of acute severe autoimmune hepatitis (AIH). Methods: A retrospective analysis of the clinical data of patients with acute severe AIH admitted to our hospital from 2008 to 2019 was divided into acute AIH (A-AIH) and chronic acute AIH (AC-AIH) according to the presence or absence of liver diseases. Patients' general condition, liver biochemistry, immunology, histological features of liver, hormonal therapies prognosis and related factors were analyzed. Results: A total of 41 cases [39 females, age (54.24 ± 10.55) years] were collected. Alanine aminotransferase (ALT) and total bilirubin (TBil) were significantly increased, and the international normalized ratio (INR) was > 1.5. Acute lobular inflammation was the feature of acute and severe AIH in the histology of liver. The serum IgG level was (28.36 ± 8.35) g / L. The positive rate of antinuclear antibody (ANA) and anti-smooth muscle antibody (ASMA) was 82.9%, and 17.1%, respectively. Over 70% of acute severe AIHs were AC-AIH. The duration of onset of AC-AIH was > 8 weeks, while most A-AIHs < 8 weeks, and the differences between the two groups were statistically significant (P = 0.001). The mortality rate within 30 days after hormonal treatment was 19.5%. There were statistically significant differences in TBil, Model for End-Stage Liver Disease (MELD) score and leukocyte count between the death and survival group. Conclusion: The mortality rate in acute severe AIH is high, and most of them have the basis of chronic liver disease. Serum IgG level, autoantibodies and acute lobular inflammation are important factors for diagnosis. The prognosis of hormonal therapy is related to the patients' condition and course of disease.


Subject(s)
Adult , Autoantibodies , End Stage Liver Disease , Female , Hepatitis, Autoimmune/diagnosis , Humans , Middle Aged , Prognosis , Retrospective Studies , Severity of Illness Index
20.
Chinese Journal of Surgery ; (12): 396-400, 2022.
Article in Chinese | WPRIM | ID: wpr-935628

ABSTRACT

Liver transplant is an unreplaceable method for benign end-stage liver disease. The risk evaluation for the waiting list recipients and for post-transplant survival could provide practical indication for organ allocation. In recent years, there are two major kinds of evaluation scores. The first kind of evaluation scores is based on model for end-stage liver disease(MELD) score,including SOFT/P-SOFT score,UCLA-FRS score and BAR score. The other evaluation system is based on the concept of acute-on-chronic liver failure,including CLIF-C-ACLF score,TAM score,AARC-ACLF score and COSSH-ACLF score. The scores based on ACLF have been shown superior power in predicting waiting list survival and post-transplant prognosis than MELD. This article reviews the two kinds of evaluation scores,aiming for the better allocation policy and the better prognosis of benign end-stage liver disease.


Subject(s)
Acute-On-Chronic Liver Failure , End Stage Liver Disease/surgery , Humans , Liver Transplantation , Prognosis , Retrospective Studies , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL